Activities per year
Activities
- 36 results
Search results
-
Post-LASIK and post-corneal injury exacerbation of late-onset lattice corneal dystrophy associated with H626R TGFBI mutation in a Canadian family
Tara Moore (Speaker)
22 Sept 2018Activity: Talk or presentation › Oral presentation
-
Evaluation of a novel FKBPL – derived peptide in the treatment of corneal neovascularisation
Tara Moore (Speaker)
9 Sept 2018Activity: Talk or presentation › Oral presentation
-
Challenges of CRISPR gene editing in genetic eye disease.
Tara Moore (Speaker)
Sept 2018Activity: Talk or presentation › Oral presentation
-
Physiological variations in pupil size and eccentricity of visual axis (angle kappa) impact quality of vision in asymmetric multifocal intraocular lens implants
Tara Moore (Speaker)
Sept 2015Activity: Talk or presentation › Oral presentation
-
Functional and neuroadaptive effects in cataract and clear lens extraction characterised via a quality of vision questionnaire.
Tara Moore (Speaker)
Sept 2015Activity: Talk or presentation › Oral presentation
-
Cyclosporine A 0.05% emulsion after cataract surgery for ocular surface problems and corneal sensation
Tara Moore (Speaker)
Sept 2015Activity: Talk or presentation › Oral presentation
-
Eyepeace’ is an effective new ‘massaging tool’ for treatment of evaporative dry eye due to obstructive meibomian gland disease
Tara Moore (Speaker)
Sept 2015Activity: Talk or presentation › Oral presentation
-
Unfolded Protein Response in a mouse model of Messmann’s Epithelial Corneal Dystrophy
Tara Moore (Speaker)
4 Sept 2015Activity: Talk or presentation › Oral presentation
-
Novel allele-specific cleavage of mutant KRT12 in vitro and in vivo by CRISPR/Cas9 through the utilisation of a SNP-derived PAM
Tara Moore (Speaker)
Sept 2015Activity: Talk or presentation › Oral presentation
-
Development of Novel Therapeutic Approaches to Corneal Disease
Tara Moore (Speaker)
20 Feb 2015Activity: Talk or presentation › Oral presentation
-
Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type
Tara Moore (Speaker)
2014Activity: Talk or presentation › Oral presentation
-
Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I
Tara Moore (Speaker)
7 May 2014Activity: Talk or presentation › Oral presentation
-
Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I
Tara Moore (Speaker)
25 Feb 2014Activity: Talk or presentation › Oral presentation
-
Development of Allele-specific Therapeutic siRNA for Meesmann's Epithelial Corneal Dystrophy
Tara Moore (Speaker)
Mar 2014Activity: Talk or presentation › Oral presentation
-
Corneal Disease in vitro and in vivo models for development of novel therapeutic approaches. From Cells to Tissues: Stem Cells, Tissue Repair and Tissue Engineering for Diabetes, Eye Disease and Neurodengerative Diseases.
Tara Moore (Speaker)
17 Sept 2014Activity: Talk or presentation › Oral presentation
-
Assessment of allele-specific gene silencing siRNAs in an ex vivo pre-clinical model of lattice type I corneal dystrophy
Tara Moore (Speaker)
6 Sept 2013Activity: Talk or presentation › Oral presentation
-
Identifying Potent and Specific siRNAs for Allele Specific Gene Silencing in Diseases Following a Dominant Negative Pathomechanism
Tara Moore (Speaker)
14 Nov 2013Activity: Talk or presentation › Oral presentation
-
Multifocals in macular disease
Tara Moore (Speaker)
29 Jun 2013Activity: Talk or presentation › Oral presentation
-
RNA interference treatment, using eye drops, validated using Meesmann’s corneal dystrophy
Tara Moore (Speaker)
2012Activity: Talk or presentation › Oral presentation
-
S10 Mutation-specific siRNA therapy for a keratin disorder
Tara Moore (Speaker)
3 Sept 2012Activity: Talk or presentation › Oral presentation
-
Mutation-specific siRNA therapy for a keratin disorder
Tara Moore (Speaker)
3 Sept 2012Activity: Talk or presentation › Oral presentation
-
Expression of NALP3 inflammasome components in human and rat conjunctival goblet cells
Tara Moore (Speaker)
2011Activity: Talk or presentation › Oral presentation
-
Pathogen or commensal: a pcr based study of ocular surface bacterial flora in normal and dry eyes
Tara Moore (Speaker)
2007Activity: Talk or presentation › Oral presentation
-
Ocular Surface Bacterial Flora - A Conundrum
Tara Moore (Speaker)
2006Activity: Talk or presentation › Oral presentation
-
Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with Conjunctival Goblet Cells
Tara Moore (Speaker)
2006Activity: Talk or presentation › Oral presentation
-
Efficacy of an in-vivo antibody based assay for the detection of herpes simplex keratitis
Tara Moore (Speaker)
2005Activity: Talk or presentation › Oral presentation
-
The effect of atmospheric plasma surface treatment of poly(methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression
Tara Moore (Speaker)
2004Activity: Talk or presentation › Oral presentation
-
Herpes Simplex Keratitis Research Project
Tara Moore (Speaker)
2004Activity: Talk or presentation › Oral presentation
-
The effect of atmospheric plasma surface treatment of poly (methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression
Tara Moore (Speaker)
2004Activity: Talk or presentation › Oral presentation
-
The Analysis of Bacterial Flora In Dry Eye
Tara Moore (Speaker)
2004Activity: Talk or presentation › Oral presentation
-
Comparison of routine bacteriology culture to molecular detection methods for analysis of ocular bacterial flora
Tara Moore (Speaker)
2004Activity: Talk or presentation › Oral presentation
-
Laboratory Research Techniques
Tara Moore (Speaker)
1999Activity: Talk or presentation › Oral presentation
-
Antisense to the receptor for AGE inhibits AGE-mediated proliferation in Vascular Endothelial Cells
Tara Moore (Speaker)
1999Activity: Talk or presentation › Oral presentation
-
Nuclear Factor Kappa Beta and Activator Protein 1 are Activated by Glucose in Vascular Smooth Muscle Cells
Tara Moore (Speaker)
1998Activity: Talk or presentation › Oral presentation
-
Glucose Activation of Nuclear Factor Kappa Beta in Vascular Smooth Muscle Cells
Tara Moore (Speaker)
1998Activity: Talk or presentation › Oral presentation
-
Nuclear Factor Kappa Beta – an Overview
Tara Moore (Speaker)
1997Activity: Talk or presentation › Oral presentation